330 related articles for article (PubMed ID: 28091594)
1. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
[TBL] [Abstract][Full Text] [Related]
2. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y
EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397
[TBL] [Abstract][Full Text] [Related]
3. Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.
Sun Y; Bao Y; Han W; Song F; Shen X; Zhao J; Zuo J; Saffen D; Chen W; Wang Z; You X; Wang Y
Nucleic Acids Res; 2017 Aug; 45(14):8524-8540. PubMed ID: 28586478
[TBL] [Abstract][Full Text] [Related]
4. The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma.
Li Z; Xue Q; Xu J; Zhang P; Ding B
Cell Cycle; 2020 Nov; 19(21):2918-2926. PubMed ID: 33064970
[TBL] [Abstract][Full Text] [Related]
5. RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition.
Bao Y; Zhang S; Zhang X; Pan Y; Yan Y; Wang N; Ren Y; Zuo J; Zong WX; Wang Z; Wang Y
Cancer Res; 2023 May; 83(9):1490-1502. PubMed ID: 36853175
[TBL] [Abstract][Full Text] [Related]
6. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor properties of the splicing regulatory factor RBM10.
Hernández J; Bechara E; Schlesinger D; Delgado J; Serrano L; Valcárcel J
RNA Biol; 2016; 13(4):466-72. PubMed ID: 26853560
[TBL] [Abstract][Full Text] [Related]
8. RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.
Cao Y; Geng J; Wang X; Meng Q; Xu S; Lang Y; Zhou Y; Qi L; Wang Z; Wei Z; Yu Y; Jin S; Pan B
Int J Biol Sci; 2022; 18(1):124-139. PubMed ID: 34975322
[TBL] [Abstract][Full Text] [Related]
9. RBM10, a New Regulator of p53.
Jung JH; Lee H; Zeng SX; Lu H
Cells; 2020 Sep; 9(9):. PubMed ID: 32947864
[TBL] [Abstract][Full Text] [Related]
10. Investigation of
Cao Y; Lan D; Ke X; Zheng W; Zeng J; Niu N; Fu C; Deng W; Jin S
Heliyon; 2024 Jun; 10(11):e32287. PubMed ID: 38912481
[TBL] [Abstract][Full Text] [Related]
11. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
Tessier SJ; Loiselle JJ; McBain A; Pullen C; Koenderink BW; Roy JG; Sutherland LC
BMC Res Notes; 2015 Feb; 8():46. PubMed ID: 25889998
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma.
Wu Q; Feng L; Wang Y; Mao Y; Di X; Zhang K; Cheng S; Xiao T
Signal Transduct Target Ther; 2022 Aug; 7(1):270. PubMed ID: 35989380
[TBL] [Abstract][Full Text] [Related]
13. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.
Jin X; Di X; Wang R; Ma H; Tian C; Zhao M; Cong S; Liu J; Li R; Wang K
J Cell Mol Med; 2019 Jun; 23(6):3897-3904. PubMed ID: 30955253
[TBL] [Abstract][Full Text] [Related]
14. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
15. Dengue virus targets RBM10 deregulating host cell splicing and innate immune response.
Pozzi B; Bragado L; Mammi P; Torti MF; Gaioli N; Gebhard LG; García Solá ME; Vaz-Drago R; Iglesias NG; García CC; Gamarnik AV; Srebrow A
Nucleic Acids Res; 2020 Jul; 48(12):6824-6838. PubMed ID: 32432721
[TBL] [Abstract][Full Text] [Related]
16. The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development.
Rodor J; FitzPatrick DR; Eyras E; Cáceres JF
RNA Biol; 2017 Jan; 14(1):45-57. PubMed ID: 27763814
[TBL] [Abstract][Full Text] [Related]
17. Functional insight into a neurodevelopmental disorder caused by missense variants in an RNA-binding protein, RBM10.
Imagawa E; Moreta L; Misra VK; Newman C; Konuma T; Oishi K
J Hum Genet; 2023 Sep; 68(9):643-648. PubMed ID: 37268768
[TBL] [Abstract][Full Text] [Related]
18. Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA.
Sutherland LC; Thibault P; Durand M; Lapointe E; Knee JM; Beauvais A; Kalatskaya I; Hunt SC; Loiselle JJ; Roy JG; Tessier SJ; Ybazeta G; Stein L; Kothary R; Klinck R; Chabot B
BMC Mol Biol; 2017 Jul; 18(1):19. PubMed ID: 28728573
[TBL] [Abstract][Full Text] [Related]
19. RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5.
Lee H; Jung JH; Ko HM; Park H; Segall AM; Sheffmaker RL; Wang J; Frey WD; Pham N; Wang Y; Zhang Y; Jackson JG; Zeng SX; Lu H
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2308292120. PubMed ID: 38032932
[TBL] [Abstract][Full Text] [Related]
20. RBM10: Structure, functions, and associated diseases.
Inoue A
Gene; 2021 May; 783():145463. PubMed ID: 33515724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
